✦ LIBER ✦

Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis

✍ Scribed by J.E. Martínez-Rodríguez; M. López-Botet; E. Munteis; J. Rio; J. Roquer; X. Montalban; M. Comabella

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natural killer receptors distribution in

✍ J.E. Martínez-Rodríguez; A. Saez-Borderías; E. Munteis; N. Romo; J. Roquer; M. L 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 867 KB

Predictors of long–term clinical respons

✍ V. Tomassini; A. Paolillo; P. Russo; E. Giugni; L. Prosperini; C. Gasperini; G. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 261 KB

One-year MRI scan predicts clinical resp

✍ L. Prosperini; V. Gallo; N. Petsas; G. Borriello; C. Pozzilli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

HLA class II and response to interferon-

✍ O. Fernández; V. Fernández; C. Mayorga; M. Guerrero; A. León; J. A. Tamayo; A. A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Genome-Wide Pharmacogenomic Analysis of

✍ Byun, Esther; Caillier, Stacy J.; Montalban, Xavier; Villoslada, Pablo; Fernánde 📂 Article 📅 2008 🏛 American Medical Association 🌐 English ⚖ 130 KB

Cytokine changes during interferon-beta

✍ Jerome J. Graber; David Ford; Min Zhan; Gordon Francis; Hillel Panitch; Suhayl D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 196 KB